Lamivudine Tablets IP 150 mg Exporter in India – Healthy Inc

Lamivudine Tablets IP 150 mg | Exporter
Product image for Lamivudine Tablets IP 150 mg Exporter; regulatory dossiers & international shipping.
Product Information
| Generic Name | Lamivudine |
|---|---|
| Manufacturer | Healthy Life Pharma Pvt. Ltd. |
| HSN Code | 30049099 |
| Pharmacopoeia | IP |
| Product Type | Tablet |
| Category | Antiviral drugs |
| Subcategory | Antiviral drugs |
| Active Ingredient | Lamivudine |
| Strength | 150 mg |
| Dosage Form | Tablet |
| Pack Size | 10 x 10 Tablets / Box (Alu-Alu / Blister) |
| Route of Administration | Oral |
| Prescription Required | Yes |
| Therapeutic Category | Antiviral drugs |
Medicine Details & Safety
| Short Description | Healthy Inc invites international procurement enquiries for Lamivudine Tablets IP 150 mg manufactured by Healthy Life Pharma. Importers and overseas distributors can submit destination-country requirements for assessment of registration documentation, export artwork and shipment feasibility. | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Approved Uses / Indications | 1. Treatment of initial and recurrent mucocutaneous and genital Herpes Simplex (HSV-1, HSV-2) outbreaks. 2. Management of Herpes Zoster (shingles), Varicella (chickenpox), and suppression of recurrent viral infections. | ||||||||||||||||||||||||
| Full Description | Healthy Inc invites international procurement enquiries for Lamivudine Tablets IP 150 mg manufactured by Healthy Life Pharma. Importers and overseas distributors can submit destination-country requirements for assessment of registration documentation, export artwork and shipment feasibility. Product technical specifications
Product technical specifications
Export regulatory and dossier readinessIdentify the destination authority and registration pathway. Request confirmation of CTD or ACTD dossier availability, COPP, Free Sale Certificate and current GMP documentation as applicable. Confirm COA and analytical files for the proposed product and market.Climatic zone stability and export artworkFor Lamivudine Tablets IP 150 mg, request stability evidence appropriate to the importing market, including Zone IVb where required. Confirm shelf life, storage conditions and multilingual carton, blister and leaflet artwork against approved documentation.Global logistics and trade termsSpecify the destination, shipment size and required delivery window. Evaluate air freight or LCL/FCL sea freight from Mumbai where feasible. Agree EXW, FOB, CIF or CIP as appropriate to the transport mode and contract; confirm freight, insurance and customs responsibilities.International buyer requirementsEnquiries may identify Africa, LATAM, Middle East, CIS or APAC as target regions. Market authorization, import permits, document availability and shipment acceptance must be confirmed for each country; this is not a statement of existing registrations. | ||||||||||||||||||||||||
| Dosage Instructions | Administer orally with plenty of fluids. Initiate therapy at the earliest symptom of viral outbreak or prodromal tingling. Adhere strictly to the dosing schedule for the full recommended duration. | ||||||||||||||||||||||||
| Side Effects | Common: Nausea, headache, diarrhea, abdominal pain, fatigue, mild pruritus. Uncommon: Dizziness, fever, skin rash, arthralgia, transient elevation in bilirubin. Rare: Reversible neurological disturbances, renal tubular crystallization in dehydration. | ||||||||||||||||||||||||
| Warnings and Precautions | Adequate Hydration: Maintain abundant fluid intake throughout therapy to avoid crystalluria and renal tubular damage. Renal Dose Adjustment: Dose reduction is mandatory in renal impairment based on creatinine clearance. Early Initiation: Therapeutic efficacy is maximal when started within 24 to 72 hours of outbreak. | ||||||||||||||||||||||||
| Contraindications | 1. Known hypersensitivity to Lamivudine or chemically related nucleoside antiviral analogues. 2. Severe uncorrected dehydration. 3. Severe acute renal failure unless coordinated with hemodialysis. | ||||||||||||||||||||||||
| Drug Interactions | 1. Probenecid & Cimetidine: Compete for active renal tubular secretion, increasing antiviral AUC and elimination half-life. 2. Nephrotoxic Medications (Aminoglycosides, Cyclosporine, Amphotericin): Synergistic potential for renal injury. 3. Mycophenolate Mofetil: Co-administration elevates plasma concentrations of both compounds. |
Frequently Asked Questions
| Question | Answer |
|---|---|
| Which registration documents can be requested for Lamivudine Tablets IP 150 mg? | Specify CTD/ACTD, COPP, FSC, COA and stability requirements for availability review. |
| Is Zone IVb data available for Lamivudine Tablets IP 150 mg? | Request confirmation for the exact formulation and packaging configuration. |
| Can export artwork be multilingual for Lamivudine Tablets IP 150 mg? | Provide the required languages and approved regulatory artwork for review. |
| Which shipping terms can be discussed for Lamivudine Tablets IP 150 mg? | EXW, FOB, CIF and CIP may be evaluated according to shipment mode and agreement. |
| How do I obtain an export quotation for Lamivudine Tablets IP 150 mg? | Provide destination country, quantity, documentation requirements and preferred trade terms. |
Related Products
✚
Lamivudine Tablets IP 100 mg ExporterView product →
✚
Lamivudine Tablets IP 100 mg ManufacturerView product →
✚
Lamivudine Tablets IP 100 mg SupplierView product →
✚
Lamivudine Tablets IP 150 mg ManufacturerView product →
✚
Lamivudine Tablets IP 150 mg SupplierView product →
✚
Adefovir Dipivoxil Tablets 10 mg ExporterView product →
✚
Adefovir Dipivoxil Tablets 10 mg ManufacturerView product →
✚
Adefovir Dipivoxil Tablets 10 mg SupplierView product →
✚
Lamivudine and Zidovudine Tablets IP 300 mg + 150 mg ExporterView product →
✚
Lamivudine and Zidovudine Tablets IP 300 mg + 150 mg ManufacturerView product →
✚
Lamivudine and Zidovudine Tablets IP 300 mg + 150 mg SupplierView product →
✚
Lopinavir and Ritonavir Tablets IP 200 mg + 50 mg ExporterView product →
Latest Posts
✚
WHO GMP certfied Glibenclamide Metformin SR TabletsRead article →✚
WHO GMP certfied Frusemide Tablets ManufacturerRead article →✚
Folic Acid Niacinamide Tablets ManufacturerRead article →✚
WHO GMP certfied Folic Acid Tablets ManufacturerRead article →✚
WHO GMP certfied Fluconazole Tablets ManufacturerRead article →✚
WHO GMP certfied Ferrous Sulphate with folic acid TabletsRead article →✚
WHO GMP certfied iron with folic acid Tablets ManufacturerRead article →✚
WHO GMP certfied Ferrous Sulphate Tablets ManufacturerRead article →